China-Biotics, Inc. (OTCMKTS:CHBT) is a biotech company headquartered in Chengdu, Sichuan Province, China, with a corporate office in Irvine, California. Since its founding in 2011, the company has focused on the research, development, manufacturing and distribution of probiotic and nutraceutical products designed to support digestive health, immune function and overall wellness. China-Biotics holds key certifications including GMP and ISO, and operates state-of-the-art production facilities that adhere to international quality standards.
The company’s product portfolio spans probiotic capsules, powders and functional beverages, as well as prebiotic and postbiotic formulations. These products are marketed under proprietary brands and private-label agreements and cater to consumer needs in areas such as gastrointestinal balance, respiratory health and skin vitality. China-Biotics emphasizes innovative strain development and collaborates with academic research centers to introduce new applications of microbial science.
Domestically, China-Biotics has built a distribution network covering more than 20 provinces, supplying hospitals, pharmacies, health and wellness stores, and major e-commerce platforms such as Alibaba and JD.com. Internationally, the company exports probiotic ingredients and finished products to markets across Southeast Asia, the Middle East and North America, leveraging partnerships with regional distributors and contract manufacturers to expand its global footprint.
The company’s leadership team is led by Chief Executive Officer Dr. Ming Xu, who brings over two decades of experience in microbiology and functional food innovation. He is supported by Chief Financial Officer Li Wang and a board of scientific advisors drawn from leading universities and research institutes. Together, they guide China-Biotics in its mission to advance probiotic science and deliver high-quality health solutions worldwide.
AI Generated. May Contain Errors.
